Cargando…
P1670: LONG TERM SAFETY AND EFFICACY OF RECOMBINANT HUMAN COAGULATION FACTOR VIII (SCT800) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430633/ http://dx.doi.org/10.1097/01.HS9.0000849536.75261.f1 |
| _version_ | 1784779824798105600 |
|---|---|
| author | Xue, F. Zhao, X. Sun, J. Zeng, X. Yang, F. Xu, M. Yu, Z. Gu, W. Feng, Y. Li, W. Zheng, C. Bi, H. Ma, C. Gai, W. Xie, L. Yang, R. |
| author_facet | Xue, F. Zhao, X. Sun, J. Zeng, X. Yang, F. Xu, M. Yu, Z. Gu, W. Feng, Y. Li, W. Zheng, C. Bi, H. Ma, C. Gai, W. Xie, L. Yang, R. |
| author_sort | Xue, F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430633 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94306332022-08-31 P1670: LONG TERM SAFETY AND EFFICACY OF RECOMBINANT HUMAN COAGULATION FACTOR VIII (SCT800) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A Xue, F. Zhao, X. Sun, J. Zeng, X. Yang, F. Xu, M. Yu, Z. Gu, W. Feng, Y. Li, W. Zheng, C. Bi, H. Ma, C. Gai, W. Xie, L. Yang, R. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430633/ http://dx.doi.org/10.1097/01.HS9.0000849536.75261.f1 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Xue, F. Zhao, X. Sun, J. Zeng, X. Yang, F. Xu, M. Yu, Z. Gu, W. Feng, Y. Li, W. Zheng, C. Bi, H. Ma, C. Gai, W. Xie, L. Yang, R. P1670: LONG TERM SAFETY AND EFFICACY OF RECOMBINANT HUMAN COAGULATION FACTOR VIII (SCT800) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A |
| title | P1670: LONG TERM SAFETY AND EFFICACY OF RECOMBINANT HUMAN COAGULATION FACTOR VIII (SCT800) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A |
| title_full | P1670: LONG TERM SAFETY AND EFFICACY OF RECOMBINANT HUMAN COAGULATION FACTOR VIII (SCT800) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A |
| title_fullStr | P1670: LONG TERM SAFETY AND EFFICACY OF RECOMBINANT HUMAN COAGULATION FACTOR VIII (SCT800) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A |
| title_full_unstemmed | P1670: LONG TERM SAFETY AND EFFICACY OF RECOMBINANT HUMAN COAGULATION FACTOR VIII (SCT800) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A |
| title_short | P1670: LONG TERM SAFETY AND EFFICACY OF RECOMBINANT HUMAN COAGULATION FACTOR VIII (SCT800) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A |
| title_sort | p1670: long term safety and efficacy of recombinant human coagulation factor viii (sct800) in previously treated patients with severe hemophilia a |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430633/ http://dx.doi.org/10.1097/01.HS9.0000849536.75261.f1 |
| work_keys_str_mv | AT xuef p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT zhaox p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT sunj p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT zengx p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT yangf p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT xum p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT yuz p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT guw p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT fengy p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT liw p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT zhengc p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT bih p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT mac p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT gaiw p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT xiel p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa AT yangr p1670longtermsafetyandefficacyofrecombinanthumancoagulationfactorviiisct800inpreviouslytreatedpatientswithseverehemophiliaa |